Lowering of blood pressure achieved through use of hashish-like drugJune 19, 2006A new method for lowering blood pressure (hypertension) through use of a compound that synthesizes a cannabis (hashish) plant component has been developed by a pharmacology Ph.D. student at the Hebrew University of Jerusalem School of Pharmacy. For his work on the cardiovascular activity of cannabinoids (chemical compounds derived from cannabis), Yehoshua Maor was one of the winners of this year's Kaye Innovation Awards, presented on June 13 during the Hebrew University of Jerusalem's 69th meeting of the Board of Governors. Cardiovascular disease (CVD) accounts for about one-third of all deaths in industrialized countries, and is the leading reason for visits there to physicians as well as for drug prescriptions. However, not all patients respond well to the drugs available. There is no 'ideal' (blood pressure lowering) drug. The cannabis plant - also known as hashish or marijuana - through its chemical compounds -- cannabinoids -- has been shown to have a beneficial, hypotensive effect. However, a drawback in the therapeutic use of cannabinoids has been its undesirable psychotropic properties - production of hallucinatory effects. Attempts to separate the hypotensive action from the psychotropic properties of cannabinoids have achieved only partial success until now. Working under the supervision of Prof. Raphael Mechoulam at the Hebrew University School of Pharmacy, Maor, who was born in Brazil and immigrated to Israel in 1998, has created a synthetic version of a minor cannabis constituent named cannabigerol, which is devoid of psychotropic activity. In laboratory experiments with rats in collaboration with Prof. Michal Horowitz of the Department of Environmental Physiology, it was found that this novel compound reduced blood pressure when administered to the rats in relatively low doses. Additional testing also showed that the compound also brought about another beneficial effect -- relaxation of the blood vessels. A further beneficial property observed in work carried out with Prof. Ruth Gallily of the Lautenberg Center for General and Tumor Immunology, was that the compounds produced an anti-inflammatory response. Maor believes that these qualities have the potential for development of a valuable new clinical drug with a major market potential, especially for patients suffering from inflammation of the blood vessels as the result of hypertension, and others with metabolic irregularities. Maor already has won international recognition for his work with cannabanoids, resulting from his collaborative work with Garry Milman, another Ph.D. student in the laboratory of Prof. Mechoulam, for the discovery of an endogenous compound found in the brain which causes vaso-relaxation. Maor begin a post-doctoral fellowship in the fall at the Harvard University Medical School, where he plans to continue his research. The Hebrew University of Jerusalem |
|||||||||||||||||||||
| Related Hashish Current Events and Hashish News Articles Lab study shows THC exposure as adolescents linked to negative effects of THC as adults In earlier studies, researchers at Louisiana State University had found that estrogen -- or more precisely, having ovaries -- made adult rats exposed for the first time to THC, the primary ingredient in marijuana and hashish, less sensitive to THC's negative effects on tests of learning and memory. The endocannabinoids: Functional roles and therapeutic opportunities Cannabis (marijuana) is the most widely produced plant-based illicit drug worldwide and the illegal drug most frequently used in Europe. Its use increased in almost all EU countries during the 1990s, in particular among young people, including school students. Role seen for cannabis in helping to alleviate allergic skin disease Administering a substance found in the cannabis plant can help the body's natural protective system alleviate an allergic skin disease (allergic contact dermatitis), an international group of researchers from Germany, Israel, Italy, Switzerland and the U.S. has found. Cannabinoids produced in the human body have an anti-inflammatory effect Endocannabinoids seem to play an important role in regulating inflammation processes. Scientists from the University of Bonn have discovered this in experiments on mice. Enhancing activity of marijuana-like chemicals in brain helps treat Marijuana-like chemicals in the brain may point to a treatment for the debilitating condition of Parkinson's disease. Hold the Hookah: Researcher warns against trendy tobacco use The growing fad of smoking tobacco through a waterpipe, sometimes known as a hookah, is rapidly turning into a worrisome epidemic. Hebrew University scientists develop prototype drug to prevent osteoporosis Substances produced in the body that act like those found in the cannabis plant help preserve bone density, according to researchers at the Hebrew University of Jerusalem. Based on this finding, a prototype for a new drug to prevent osteoporosis (loss of bone density) without any psychoactive side effects has already been developed. More Hashish Current Events and Hashish News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||